Patients Get FDA's Ear, Opening Door To Relaxed Approvals
The U.S. Food and Drug Administration is poised to take patient perspectives on risks and benefits into account like never before, raising the possibility that regulators will apply a slightly relaxed...To view the full article, register now.
Already a subscriber? Click here to view full article